Dapagliflozin reduces cardiovascular death risk in patients with preserved ejection fraction
Results were presented at European Society of Cardiology Congress 2022, and published in 'New England Journal of Medicine'
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.